Change in access blood flow over time predicts vascular access thrombosis.

PubWeight™: 1.03‹?› | Rank: Top 15%

🔗 View Article (PMID 9844149)

Published in Kidney Int on November 01, 1998

Authors

N R Neyra1, T A Ikizler, R E May, J Himmelfarb, G Schulman, Y Shyr, R M Hakim

Author Affiliations

1: Department of Medicine, Division of Nephrology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Articles by these authors

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA (2001) 4.75

A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int (2007) 4.68

Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol (2001) 4.16

Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med (1995) 3.91

Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology (2000) 3.32

Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: a p53-independent induction of p21WAF1/CIP1 via C/EBPbeta. Nat Med (1997) 2.32

Mortality after acute renal failure: models for prognostic stratification and risk adjustment. Kidney Int (2006) 2.29

Initiation of dialysis. J Am Soc Nephrol (1995) 2.16

Variability in Cobb angle measurements in children with congenital scoliosis. J Bone Joint Surg Br (1995) 2.03

Insulin resistance is associated with skeletal muscle protein breakdown in non-diabetic chronic hemodialysis patients. Kidney Int (2006) 1.97

Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: a prospective study. Kidney Int (1999) 1.89

Helicobacter pylori genotypes, host factors, and gastric mucosal histopathology in peptic ulcer disease. Hum Pathol (2001) 1.87

Casemix adjustment of managed care claims data using the clinical classification for health policy research method. Med Care (1998) 1.83

The dose of hemodialysis and patient mortality. Kidney Int (1996) 1.82

Polycystin: in vitro synthesis, in vivo tissue expression, and subcellular localization identifies a large membrane-associated protein. Proc Natl Acad Sci U S A (1997) 1.75

Prescribed versus delivered dialysis in acute renal failure patients. Am J Kidney Dis (1998) 1.74

Intussusception in the adult. Aust N Z J Surg (1981) 1.68

Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney Int (2000) 1.66

Reamed intramedullary nailing of the femur: 551 cases. J Trauma (1999) 1.63

Design and statistical issues of the hemodialysis (HEMO) study. Control Clin Trials (2000) 1.60

Analysis of the genomic sequence for the autosomal dominant polycystic kidney disease (PKD1) gene predicts the presence of a leucine-rich repeat. The American PKD1 Consortium (APKD1 Consortium). Hum Mol Genet (1995) 1.59

Detection of granulocyte reactive oxygen species formation in whole blood using flow cytometry. Cytometry (1992) 1.59

Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice. Cancer Res (2001) 1.58

Preoperative risk factor assessment in liver transplantation. Surgery (1992) 1.55

Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis. N Engl J Med (1985) 1.55

Association of intradialytic blood pressure changes with hospitalization and mortality rates in prevalent ESRD patients. Kidney Int (2007) 1.54

Cardiac troponin-I accurately predicts myocardial injury in renal failure. Nephrol Dial Transplant (1998) 1.50

Early post-prostatectomy pelvic floor biofeedback. J Urol (2000) 1.44

Beta-2-microglobulin amyloidosis in long-term dialysis patients. Am J Nephrol (1989) 1.42

Vascular access for hemodialysis. Patency rates and results of revision. Ann Surg (1985) 1.40

Ambulatory blood pressure monitoring in dialysis patients and estimation of mean interdialytic blood pressure. Am J Kidney Dis (1997) 1.40

Hemodialysis access failure: a call to action. Kidney Int (1998) 1.39

Use of vascular access blood flow to evaluate vascular access. Am J Kidney Dis (2001) 1.38

A novel united network for organ sharing region kidney allocation plan improves transplant access for minority candidates. Transplantation (1999) 1.37

Acute emphysematous cholecystitis. Br J Surg (1971) 1.32

Spontaneous dietary protein intake during progression of chronic renal failure. J Am Soc Nephrol (1995) 1.31

Complement activation and hypersensitivity reactions to dialysis membranes. N Engl J Med (1984) 1.25

Effects of celecoxib and naproxen on renal function in the elderly. Arch Intern Med (2000) 1.24

Hypertension and proteinuria: long-term sequelae of uninephrectomy in humans. Kidney Int (1984) 1.22

Anti-platelet therapy in graft thrombosis: results of a prospective, randomized, double-blind study. Kidney Int (1994) 1.21

Nutrition in end-stage renal disease. Kidney Int (1996) 1.21

Surgeons' and occupational health departments' awareness of guidelines on post-exposure prophylaxis for staff exposed to HIV: telephone survey. BMJ (1999) 1.20

Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients. Clin Nephrol (2002) 1.20

Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma. J Nucl Med (1999) 1.19

Sexual dysfunction following rectal excision for ulcerative colitis. Br J Surg (1966) 1.18

Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group. Am J Kidney Dis (1996) 1.16

Vascular access blood flow monitoring reduces access morbidity and costs. Kidney Int (2001) 1.15

Acute kidney injury: changing lexicography, definitions, and epidemiology. Kidney Int (2007) 1.15

Reassessing the cardiac risk profile in chronic hemodialysis patients: a hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors. J Am Soc Nephrol (1997) 1.13

Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma. Ann Oncol (2009) 1.12

Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas. Am J Pathol (2000) 1.12

Health related quality of life assessment after radical prostatectomy in men with prostate specific antigen only recurrence. J Urol (2001) 1.11

Hemodynamic exercise testing. A valuable tool in the selection of cardiac transplantation candidates. Circulation (1996) 1.10

External beam irradiation as an adjunctive treatment in failing dialysis shunts. J Vasc Interv Radiol (2000) 1.09

Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis (1994) 1.08

Novel p63 target genes involved in paracrine signaling and keratinocyte differentiation. Cell Death Dis (2010) 1.08

Vancomycin-resistant enterococci among chronic hemodialysis patients: a prospective study of acquisition. Clin Infect Dis (2000) 1.08

Appendicolith revealed on CT in children with suspected appendicitis: how specific is it in the diagnosis of appendicitis? AJR Am J Roentgenol (2000) 1.07

Obesity and mortality in ESRD: is it good to be fat? Kidney Int (1999) 1.06

Predictive measures of vascular access thrombosis: a prospective study. Kidney Int (1997) 1.04

Abdominal wound closure: a controlled trial of polyamide (nylon) and polydioxanone suture (PDS). Ann R Coll Surg Engl (1985) 1.04

Heterosexual experiences and partnerships of urban, low-income African-American and Hispanic youth. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.03

Nuclear survivin as a biomarker for non-small-cell lung cancer. Br J Cancer (2004) 1.03

Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas. Mod Pathol (1998) 1.03

The value of the clinical history in the differentiation of syncope due to ventricular tachycardia, atrioventricular block, and neurocardiogenic syncope. Am J Med (1995) 1.03

Amino acid and albumin losses during hemodialysis. Kidney Int (1994) 1.03

Antioxidants reduce cyclooxygenase-2 expression, prostaglandin production, and proliferation in colorectal cancer cells. Cancer Res (1998) 1.02

The management of large congenital liver cysts. Postgrad Med J (1982) 1.02

The influence of molar furcation involvement and mobility on future clinical periodontal attachment loss. J Periodontol (1994) 1.01

Relationship of dialysis membrane and cause-specific mortality. Am J Kidney Dis (1999) 1.01

Increased expression of the C3b receptor by neutrophils and complement activation during haemodialysis. Clin Exp Immunol (1984) 1.01

Renal replacement therapies in the elderly: Part 1. Hemodialysis and chronic peritoneal dialysis. Am J Kidney Dis (1993) 1.00

Laparoscopic cholecystectomy in children: lessons learned from the first 100 patients. J Pediatr Surg (1999) 0.99

DNA copy number aberrations in small-cell lung cancer reveal activation of the focal adhesion pathway. Oncogene (2010) 0.99

Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein. Cancer Res (2000) 0.99

Evaluation of a collagen membrane with and without bone grafts in treating periodontal intrabony defects. J Periodontol (1995) 0.99

Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction. Am J Cardiol (1996) 0.99

Comparison of 2 clinical techniques for treatment of gingival recession. J Periodontol (2001) 0.99

Prognosis of patients with acute renal failure requiring dialysis: results of a multicenter study. Am J Kidney Dis (1998) 0.99

Evaluation of a bioactive glass alloplast in treating periodontal intrabony defects. J Periodontol (1998) 0.99